View current MadeMed programs, pricing, and enrollment details here Why This Information Matters Right Now (April 2026) The compounded GLP-1 telehealth market is shifting faster than most prospective patients realize
Many patients with diabetes find that once their glucose levels are more controlled, they can think more clearly and stay on task longer
Los probiticos no deben considerarse sustitutos de tratamientos mdicos establecidos, modificaciones dietticas o actividad fsica regular
May 1, 2026: Judge in Ozempic MDL Issues Two Discovery Orders as Number of NAION Claims Approaches 90 There are 86 claims in the multidistrict litigation about whether Ozempic and other GLP-1s caused some patients to develop NAION
The AACE/ACE, in contrast to the ADA, provides several monotherapy options that are recommended in the following order according to the strength of each recommendation: metformin, GLP-1 receptor agonist, SGLT-2 inhibitor, DPP-4 inhibitor, thiazolidinedione, -glucosidase inhibitor, and an insulin secretagogue (a sulfonylurea or meglitinide)
Reducing or avoiding them may help ease symptoms